SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

People will be able to start on Belqiv

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
FLYTYER Member Profile
 
Followed By 8
Posts 1,197
Boards Moderated 0
Alias Born 09/07/07
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/14/2017 10:48:03 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/14/2017 9:02:33 AM
Arena Pharmaceuticals Appoints Three New Members to Board of Directors "PR Newswire (US)" - 2/14/2017 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2017 1:06:55 PM
Schedule 13g "Edgar (US Regulatory)" - 2/9/2017 9:54:52 AM
Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th Congress of European Crohn's and Colitis Organisatio... "PR Newswire (US)" - 2/9/2017 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/19/2017 5:30:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/6/2017 4:48:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/4/2017 4:23:47 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/4/2017 4:20:19 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/4/2017 4:16:24 PM
Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally "PR Newswire (US)" - 1/4/2017 4:05:00 PM
Eisai and Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ® (lorcaserin HCl) in Brazil "PR Newswire (US)" - 12/19/2016 1:30:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/16/2016 5:22:09 PM
Arena Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference "PR Newswire (US)" - 12/13/2016 8:30:00 AM
Arena Pharmaceuticals Completes Enrollment in Ralinepag Phase 2 Clinical Trial for Pulmonary Arterial Hypertension (PAH) "PR Newswire (US)" - 12/7/2016 8:30:00 AM
Arena Pharmaceuticals Announces Four Upcoming Presentations at the 2016 Advances in Inflammatory Bowel Diseases: Crohn's & Co... "PR Newswire (US)" - 11/30/2016 8:30:00 AM
Arena Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference "PR Newswire (US)" - 11/9/2016 4:30:00 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 11/9/2016 4:18:30 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2016 4:09:06 PM
Arena Pharmaceuticals Announces Poster at the American Heart Association (AHA) Scientific Sessions 2016 "PR Newswire (US)" - 11/9/2016 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2016 4:37:33 PM
Arena Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update "PR Newswire (US)" - 11/7/2016 4:05:00 PM
Eisai and Arena Pharmaceuticals Announce Presentation of BELVIQ® (lorcaserin HCl) Data at 2016 Annual Obesity Week Meeting "PR Newswire (US)" - 11/3/2016 8:05:00 AM
Arena Pharmaceuticals to Release Third Quarter 2016 Financial Results and Provide Corporate Update on Monday, November 7, 201... "PR Newswire (US)" - 10/31/2016 4:30:00 PM
FLYTYER   Wednesday, 07/18/12 08:06:59 AM
Re: Kelroz post# 11635
Post # of 22366 
People will be able to start on Belqiv the day they visit their doctor. I am sure samples will be available immediately and they can start the process of losing weight the first day.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist